Bioavailability of genistein and its glycoside genistin as measured in the portal vein of freely moving unanesthetized rats

Journal of Agricultural and Food Chemistry

Volumn 54, Issue 21, 2006, Pages 8006-8012

  Steensma, Aukje ^a   Faassen Peters, Maria A W ^a   Noteborn, Hub P J M ^a,b   Rietjens, Ivonne M C M ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b Voedsel en Waren Autoriteit Netherlands   (Netherlands)

Author keywords

Bioavailability; Genistein; Genistin; Glycosides; In vivo rat study; Isoflavones; Soy

Indexed keywords

GENISTEIN; GENISTIN; ISOFLAVONE DERIVATIVE; SOYBEAN PROTEIN;

ANIMAL; ARTICLE; BIOAVAILABILITY; BLOOD; CHEMISTRY; DIET; FECES; INTESTINE; KINETICS; MALE; METABOLISM; PORTAL VEIN; RAT; WISTAR RAT;

ANIMALS; BIOLOGICAL AVAILABILITY; DIET; FECES; GENISTEIN; INTESTINES; ISOFLAVONES; KINETICS; MALE; PORTAL VEIN; RATS; RATS, WISTAR; SOYBEAN PROTEINS;

GLYCINE MAX;

EID: 33751243628     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf060783t     Document Type: Article

References (34)

1. Doll, R.; Peto, R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. Natl. Cancer Inst. 1981, 66, 1191-1308.
2. Peto, J. Cancer epidemiology in the last century and the next decade. Nature 2001, 411, 390-395.
3. Setchell, K. D. R.; Cassidy, A. Dietary isoflavones: biological effects and relevance to human health. J. Nutr. 1999, 129, 758S-767S.
4. Branca, F.; Lorenzetti, S. Health effects of phytoestrogens. Forum Nutr. 2005, 57, 100-111.
5. Sarkar, F. H.; Adsule, S.; Padhye, S.; Kulkarni, S.; Li, Y. The role of genistein and synthetic derivates of isoflavones in cancer prevention and therapy. Mini-Rev. Med. Chem. 2006, 6, 401-407.
6. Cassidy, A.; Albertazzi, P.; Nielsen, I. L.; Hall, W.; Williamson, G.; Tetens, I.; Atkins, S.; Cross, H.; Manios, Y.; Wolk, A.; Steiner, C.; Branca, F. Critical review of health effects of soyabean phyto-oestrogens in post-menopausal women. Proc. Nutr. Soc. 2006, 65, 76-92.
7. Kimira, M.; Arai, Y.; Shimoi, K.; Watanabe, S. Japanese intake of flavonoids and isoflavonoids from foods. J. Epidemiol. 1998, 8, 168-175.
8. Chen, Z.; Zheng, W.; Cluster, L. J.; Dai, Q.; Shu, X. O.; Jin, F.; Franke, A. A. Usual dietary consumption of soy foods and its correlation with the excretion rate of isoflavonoids in overnight urine samples among Chinese women in Shanghai. Nutr. Cancer 1999, 33, 82-87.
9. Van Erp-Baart, M. A.; Brandts, H. A.; Kiely, M.; Mullinga, A.; Turrini, A.; Sermonetta, C.; Kilkkinen; A.; Valsta, L. M. Isoflavone intake in four different European countries: the VENUS approach. Br. J. Nutr. 2003, 89, S25-S30.
10. Setchell, K. D. R.; Brown, N. M.; Desai, P.; Zimmet-Nechemias, L.; Wolfe, B. E.; Brashear, W. T.; Kirschner, A. S.; Cassidy, A.; Heubi, J. E. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J. Nutr. 2001, 131, 1362S-1375S.
11. Zubik, L.; Meydani, M. Bioavailability of soybean isoflavones from aglycone and glucoside forms in American women. Am. J. Clin. Nutr. 2003, 77, 1459-1465.
12. Manach, C.; Williamson, G.; Morand, C.; Scalbert, A.; Rémésy, C. Bioavailabilty and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 2005, 81 (Suppl.), 230S-242S.
13. Spencer, J. P. E.; Chowrimootoo, G.; Choudhury, R.; Debnam, E. S.; Srai, S. K.; Rice-Evans, C. The small intestine can both absorb and glucuronidate luminal flavonoids. FEBS Lett. 1999, 458, 224-230.
14. Hollman, P. C. H.; de Vries, J. H. M.; van Leeuwen, S. D.; Mengelers, M. J. B.; Katan, M. B. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am. J. Clin. Nutr. 1995, 62, 1276-1282.
15. Piskula, M. K.; Yamakoshi, J.; Iwai, Y. Daidzein and genistein but not their glucosides are absorbed from the rat stomach. FEBS Lett. 1999, 447, 287-291.
16. Izumi, T.; Piskula, M. K.; Osawa, S.; Obata, A.; Tobe, K.; Saito, M.; Kataoka, S.; Kubota, Y.; Kikuchi, M. Soy isoflavone aglycones are absorbed faster and in higher amounts than their glycosides in humans. J. Nutr. 2000, 130, 1695-1699.
17. Sfakianos, J.; Coward, L.; Kirk, M.; Barnes, S. Intestinal uptake and biliary excretion of the isoflavone genistein in rats. J. Nutr. 1997, 127, 1260-1268.
18. Van Dongen, J. J.; Remie, R.; Rensema, J. W.; Van Wunnik, G. H. J. Manual of microsurgery on the laboratory rat. In Techniques in the Behavioural and Neural Sciences; Huston, J. P., Ed.; Elsevier: Amsterdam, The Netherlands, 1990; pp 213-222.
19. Gee, J. M.; Noteborn, H. P. J. M.; Polley, A. C. J.; Johnson, I. T. Increased induction of aberrant crypt foci by 1,2-dimethylhydrazine in rats fed diets containing purified genistein or genistein-rich soya protein. Carcinogenesis 2000, 21, 2255-2259.
20. Steensma, A.; Bienenmann-Ploum, M. E.; Noteborn, H. P. J. M. Intestinal uptake of genistein and its glycoside in the rat using various isolated perfused gut segments. Environ. Toxicol. Pharmacol. 2004, 17, 103-110.
21. Setchell, K. D. R.; Brown, N. M.; Zimmer-Nechemias, L.; Brashear, W. T.; Wolfe, B. E.; Kirschner, A. S.; Heubi, J. E. Evidence for lack of absorption of soy isoflavone glycoside in humans, supporting the crucial role of intestinal metabolism for bioavailability. Am. J. Clin. Nutr. 2002, 76, 447-453.
22. 13C-labeled tracers in premenopausal women. Am. J. Clin. Nutr. 2003, 77, 411-419.
23. Bloedon, L. T.; Jeffcoat, A. R.; Lopaczynski, W.; Schell, M. J.; Blacj, T. M.; Dix, K. J.; Thomas, B. F.; Albright, C.; Busby, M. C.; Crowell, J. A.; Zeisel, S. H. Safety and pharmocokinetics of purified soy isoflavones: single-dose administration to postmenopausal women. Am. J. Clin. Nutr. 2002, 76, 1126-1137.
24. Busby, M. G.; Jeffcoat, A. R.; Bloedon L. T.; Koch, M. A.; Black, T.; Dix, K. J.; Heizer, W. D.; Thomas, B. F.; Hill, J. M.; Crowell, J. A.; Zeisel, S. H. Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men. Am. J. Clin. Nutr. 2002, 75, 126-136.
25. 14C] genistein in the rat: gender-related differences, potential mechanisms of biological action, and implications for human health. Toxicol. Appl. Pharmacol. 2000, 164, 206-215.
26. 14C] genistein in the rat; plasma pharmacokinetics of parent compound, genistein glucuronide and total radioactivity. Eur. J. Drug Metab. Pharmacokinet. 2002, 27, 249-258.
27. Sesink, A. L. A.; O'Leary, K.; Hollman, P. C. H. Quercetin glucuronides but not glucosides are present in human plasma after consumption of quercetin-3-glucoside or quercetin-4-glucoside. J. Nutr. 2001, 131, 1938-1941.
28. Andlauer, W.; Kolb, J.; Fürst, P. Absorption and metabolism of genistin in the isolated rat small intestine. FEBS Lett. 2000, 475, 127-130.
29. Andlauer, W.; Kolb, J.; Fürst, P. Phloridzin improves absorption of genistin in isolated rat small intestine. Clin. Nutr. 2004, 23, 989-995.
30. Steensma, A.; Noteborn, H. P. J. M.; Kuiper, H. A. Comparison of Caco-2, IEC-18 and HCEC cell lines as a model for intestinal absorption of genistein, daidzein and their glycosides. Environ. Toxicol. Pharmacol. 2004, 16, 131-139.
31. Setchell, K. D. R.; Brown, N. M.; Desai, P.; Zimmet-Nechemias, L.; Wolfe, B.; Jakate A. S.; Creutzinger, V.; Heubi, J. E. Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by health women at physiologically typical dietary intakes. J. Nutr. 2003, 133, 1027-1035.
32. Andlauer, W.; Kolb, J.; Fürst, P. Isoflavones from tofu are absorbed and metabolised in the isolated rat small intestine. J. Nutr. 2000, 130, 3021-3027.
33. Walle, K. U.; French, K. L.; Walgren, R. A.; Walle, T. Transport of genistein-7-glucoside by human intestinal Caco-2 cells: potential role for MRP2. Res. Commun. Mol. Pathol. Pharmacol. 1999, 103, 45-56.
34. Imai, Y.; Tsukahara, S.; Asada, S.; Sugimoto, Y. Phytoestrogens/ flavonoids reverse breast cancer resistance protein/ABCG2-mediated multidrug resistance. Cancer Res. 2004, 64, 4346-4352.